de Boer M - Search Results

1

Rhizopus oryzae skin infection treated with posaconazole in a boy with chronic granulomatous disease.

Wildenbeest JG, Oomen MW, Brüggemann RJ, de Boer M, Bijleveld Y, van den Berg JM, Kuijpers TW, Pajkrt D. Wildenbeest JG, et al. Among authors: de boer m. Pediatr Infect Dis J. 2010 Jun;29(6):578. doi: 10.1097/INF.0b013e3181dc8352. Pediatr Infect Dis J. 2010. PMID: 20508483 No abstract available.

2

Complement factor 7 gene mutations in relation to meningococcal infection and clinical recurrence of meningococcal disease.

Kuijpers TW, Nguyen M, Hopman CT, Nieuwenhuys E, Dewald G, Lankester AC, Roos A, van der Ende A, Fijen C, de Boer M. Kuijpers TW, et al. Among authors: de boer m. Mol Immunol. 2010 Jan;47(4):671-7. doi: 10.1016/j.molimm.2009.10.017. Epub 2009 Nov 22. Mol Immunol. 2010. PMID: 19931914

3

Phenotypic variation in IgG receptors by nonclassical FCGR2C alleles.

van der Heijden J, Breunis WB, Geissler J, de Boer M, van den Berg TK, Kuijpers TW. van der Heijden J, et al. Among authors: de boer m. J Immunol. 2012 Feb 1;188(3):1318-24. doi: 10.4049/jimmunol.1003945. Epub 2011 Dec 23. J Immunol. 2012. PMID: 22198951

4

Primary immunodeficiency caused by an exonized retroposed gene copy inserted in the CYBB gene.

de Boer M, van Leeuwen K, Geissler J, Weemaes CM, van den Berg TK, Kuijpers TW, Warris A, Roos D. de Boer M, et al. Hum Mutat. 2014 Apr;35(4):486-96. doi: 10.1002/humu.22519. Epub 2014 Feb 24. Hum Mutat. 2014. PMID: 24478191

5

Mutation in an exonic splicing enhancer site causing chronic granulomatous disease.

de Boer M, van Leeuwen K, Geissler J, Belohradsky BH, Kuijpers TW, Roos D. de Boer M, et al. Blood Cells Mol Dis. 2017 Jul;66:50-57. doi: 10.1016/j.bcmd.2017.08.012. Epub 2017 Aug 18. Blood Cells Mol Dis. 2017. PMID: 28886419 Free article.

6

A false-carrier state for the c.579G>A mutation in the NCF1 gene in Ashkenazi Jews.

De Boer M, Gavrieli R, van Leeuwen K, Wolf HR, Dushnitzki M, Bar-Yosef Y, Bar-Ziv A, Behar D, Lipitz S, Miller TE, Tool ATJ, Kuijpers TW, van den Berg TK, Wolach B, Roos D, Pras E. De Boer M, et al. J Med Genet. 2018 Mar;55(3):166-172. doi: 10.1136/jmedgenet-2017-105022. Epub 2018 Jan 13. J Med Genet. 2018. PMID: 29331982

7

Inherited p40phox deficiency differs from classic chronic granulomatous disease.

van de Geer A, Nieto-Patlán A, Kuhns DB, Tool AT, Arias AA, Bouaziz M, de Boer M, Franco JL, Gazendam RP, van Hamme JL, van Houdt M, van Leeuwen K, Verkuijlen PJ, van den Berg TK, Alzate JF, Arango-Franco CA, Batura V, Bernasconi AR, Boardman B, Booth C, Burns SO, Cabarcas F, Bensussan NC, Charbit-Henrion F, Corveleyn A, Deswarte C, Azcoiti ME, Foell D, Gallin JI, Garcés C, Guedes M, Hinze CH, Holland SM, Hughes SM, Ibañez P, Malech HL, Meyts I, Moncada-Velez M, Moriya K, Neves E, Oleastro M, Perez L, Rattina V, Oleaga-Quintas C, Warner N, Muise AM, López JS, Trindade E, Vasconcelos J, Vermeire S, Wittkowski H, Worth A, Abel L, Dinauer MC, Arkwright PD, Roos D, Casanova JL, Kuijpers TW, Bustamante J. van de Geer A, et al. Among authors: de boer m. J Clin Invest. 2018 Aug 31;128(9):3957-3975. doi: 10.1172/JCI97116. Epub 2018 Aug 6. J Clin Invest. 2018. PMID: 29969437 Free PMC article.

8

Genetic Characteristics, Infectious, and Noninfectious Manifestations of 32 Patients with Chronic Granulomatous Disease.

Aygun D, Koker MY, Nepesov S, Koker N, van Leeuwen K, de Boer M, Kıykım A, Ozsoy S, Cokugras H, Kuijpers T, Roos D, Camcıoglu Y. Aygun D, et al. Among authors: de boer m. Int Arch Allergy Immunol. 2020;181(7):540-550. doi: 10.1159/000507366. Epub 2020 Jun 8. Int Arch Allergy Immunol. 2020. PMID: 32512560

9

Neutrophil responsiveness to IgG, as determined by fixed ratios of mRNA levels for activating and inhibitory FcgammaRII (CD32), is stable over time and unaffected by cytokines.

van Mirre E, Breunis WB, Geissler J, Hack CE, de Boer M, Roos D, Kuijpers TW. van Mirre E, et al. Among authors: de boer m. Blood. 2006 Jul 15;108(2):584-90. doi: 10.1182/blood-2005-12-4997. Epub 2006 Mar 21. Blood. 2006. PMID: 16551965 Free article.

10

Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura.

Breunis WB, van Mirre E, Bruin M, Geissler J, de Boer M, Peters M, Roos D, de Haas M, Koene HR, Kuijpers TW. Breunis WB, et al. Among authors: de haas m, de boer m. Blood. 2008 Feb 1;111(3):1029-38. doi: 10.1182/blood-2007-03-079913. Epub 2007 Sep 7. Blood. 2008. PMID: 17827395 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,713 results

Search Page